en
svPress releases
Regulatory press release 2021-11-30
Number of shares and votes in Xspray Pharma
Press release 2021-11-18
Xspray Pharma submits application for market approval to FDA for its product candidate Dasynoc
Press release 2021-11-15
Xspray Pharma strengthens the organization with IR and Communications function
Regulatory press release 2021-11-08
Xspray Pharma completes a directed new share issue to Flerie Invest, raising approximately SEK 100 million
Regulatory press release 2021-10-26
Xspray Pharma publishes interim report Q3, January – September 2021
Regulatory press release 2021-10-25
Xspray Pharma brings forward publication of the Q3 interim report
Regulatory press release 2021-10-15
Xspray Pharma’s Nomination Committee for the Annual General Meeting 2022
Regulatory press release 2021-10-13
Xspray Pharma has obtained results from bioequivalence studies with HyNap-Dasa ANDA and decides to focus on its improved dasatinib product, Dasynoc™
Press release 2021-08-30
All participants in Xspray Pharma studies have received their dose of generic version of dasatinib, HyNap-Dasa ANDA
Press release 2021-08-06